Navigation Links
Wyeth to Present at the Credit Suisse First Boston Healthcare Conference
Date:11/8/2007

MADISON, N.J., Nov. 8 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) announced today that it will present at the Credit Suisse First Boston Healthcare Conference on Tuesday, November 13, 2007 at 11:00 a.m. Eastern Time. Presenting for Wyeth will be Joseph M. Mahady, Senior Vice President, Wyeth and President, Wyeth Pharmaceuticals Global Business.

Wyeth's presentation will be webcast live for investors at http://www.wyeth.com and available for replay following the conference.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products, and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare, and Fort Dodge Animal Health.


'/>"/>
SOURCE Wyeth
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Wyeth and Nycomed Announce Court Denial of Preliminary Injunction
2. Wyeths Pearl River, N.Y. Facility Celebrates 100 Years of Achievements in Health care
3. Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
4. Wyeth Announces the Election of Robert M. Amen to Its Board of Directors
5. Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease
6. Wyeth to Appeal Nevada Hormone Therapy Trial Verdict
7. Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months
8. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
9. Wyeth Consumer Healthcare Announces the Availability of Centrum Cardio and New Formula Centrum Products
10. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
11. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 The Alaska ... hiring of new dentist Dr. Jonathan Oudin, DDS, who ... previously practiced in Barrow, Alaska, for three years. According ... Dentistry hired Dr. Oudin to help take on new ... Dentistry to continue growing and serving the greater Anchorage ...
(Date:7/31/2014)... THURSDAY, July 31, 2014 (HealthDay News) -- With the ... the West African Ebola outbreak has risen to 729, ... on Thursday issued a travel warning for,the region. ... travel to the affected countries -- Guinea, Liberia and ... is that Ebola is worsening in West Africa," CDC ...
(Date:7/31/2014)... Scientists have learned that recent fears of invasive lionfish ... efforts to control lionfish by fishing derbies and targeted ... invasion. And there,s a simple way to know for ... after it,s been cooked. , Pacific lionfish were first ... and have been gaining swiftly in number ever since. ...
(Date:7/31/2014)... 31, 2014 Insight Accelerator Labs member ... A round of investment for $4.6 million to fund ... collecting vital signs. The company joined Insight Accelerator ... fruition with the help of Insight development teams. ... for launching the Accelerator,” says Steve McPhilliamy, Executive Director ...
(Date:7/31/2014)... FL (PRWEB) July 31, 2014 Women ... to take charge of their financial future. The ... women, has opened registration for 6 upcoming Los Angeles ... women, for women, and with input from Kim Kiyosaki, ... and It’s Rising Time) who is passionate about women’s ...
Breaking Medicine News(10 mins):Health News:Dr. Jonathan Oudin to Join Alaska Center for Dentistry at Wasilla Location 2Health News:CDC Issues Travel Warning as West Africa Ebola Outbreak Worsens 2Health News:Invasive lionfish likely safe to eat after all 2Health News:Invasive lionfish likely safe to eat after all 3Health News:Insight Accelerator Labs Advances Member Toward Commercialization 2Health News:Insight Accelerator Labs Advances Member Toward Commercialization 3Health News:The Independent Woman to Offer Financial Workshops in the Los Angeles Area - Developed by Women for Women 2
... 31 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE:,MDZ), ... the global life,sciences markets, announced today that Stephen ... presenting at the Thomas Weisel Partners,Healthcare Conference in ... Standard Time. Interested parties may access the ...
... 31 Mylan Laboratories Inc.,(NYSE: MYL ) ("Mylan") ... for cash any and all of its outstanding 5.750% ... Notes due 2015 (CUSIP Nos.,628530AF4, 628530AC1) (collectively, the "Notes"). ... of a broader strategy to,establish its new global capital ...
... - QLT USA, Inc., a subsidiary,of QLT Inc. ... that the European,approval procedure for the Eligard(R) 45 ... formulation in 23 European countries,is expected to follow ... the individual countries. The 6-month formulation was launched ...
... UHW-West and 121RN, their, first ever wage scales ... Calif., Aug. 30 Caregivers at Providence St.,Joseph Medical ... -,West (UHW) and SEIU 121RN, reached a tentative agreement ... contract, which expires,Sept. 30, 2011, grants workers their first ...
... are likely culprits behind the increase, , , THURSDAY, Aug. ... in one sport early -- playing year-round, joining competitive ... programs -- believing they,ll put themselves on the fast ... sports career. , But for too many of these ...
... Over Health & Safety of,Seniors in Nursing Homes, ... death linked to an untreated oral infection, the,statewide organization ... oral health of seniors residing in nursing and,convalescent homes., ... it can be a matter of life and,death, especially ...
Cached Medicine News:Health News:Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Merck's Generic Pharmaceutical Business 2Health News:Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Merck's Generic Pharmaceutical Business 3Health News:Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Merck's Generic Pharmaceutical Business 4Health News:Eligard(R) six-month formulation successfully completes European approval procedure 2Health News:Eligard(R) six-month formulation successfully completes European approval procedure 3Health News:Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract 2Health News:More Kids Are Suffering Sports Injuries 2Health News:More Kids Are Suffering Sports Injuries 3Health News:Oral Health a Matter of Life and Death for Seniors 2
(Date:7/31/2014)... July 31, 2014   Auxilium Pharmaceuticals , Inc. ... biopharmaceutical company, today announced that the Company will release ... August 7, 2014 before the opening of the U.S. ... call that day at 8:30 a.m. ET to discuss ... The presentation slides to be used during the call ...
(Date:7/31/2014)... , July 31, 2014  A substantial share ... decisions about which therapies are included in formularies—say ... according to a new Manhattan Research study, ... The study finds that P&T committee members in ... managers (PBMs) have set a high bar for ...
(Date:7/31/2014)... Catylix, Inc. ( Burbank, California ... California ) announced today the formation of ... fluorination products and related chemistry. Developing ... use of substituents that are chemically stable, resistant ... improve binding and bioavailability. Fluorinated functional groups are ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 2Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 3Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2
... FDA Clearance for a Phase II Trial of Its Long-Acting... -- NES-ZIONA, Israel, Aug. 24 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... CHICAGO, Aug. 24 Advanced Life Sciences Holdings, ... a biopharmaceutical company engaged in the discovery, development and ... infection, oncology and respiratory diseases, today announced plans to ... once-daily antibiotic, Restanza™ (cethromycin) based on a new, high-profile ...
Cached Medicine Technology:PROLOR Biotech Receives FDA Clearance for a Phase II Trial of Its Long-Acting Human Growth Hormone in the U.S. 2PROLOR Biotech Receives FDA Clearance for a Phase II Trial of Its Long-Acting Human Growth Hormone in the U.S. 3PROLOR Biotech Receives FDA Clearance for a Phase II Trial of Its Long-Acting Human Growth Hormone in the U.S. 4PROLOR Biotech Receives FDA Clearance for a Phase II Trial of Its Long-Acting Human Growth Hormone in the U.S. 5PROLOR Biotech Receives FDA Clearance for a Phase II Trial of Its Long-Acting Human Growth Hormone in the U.S. 6PROLOR Biotech Receives FDA Clearance for a Phase II Trial of Its Long-Acting Human Growth Hormone in the U.S. 7PROLOR Biotech Receives FDA Clearance for a Phase II Trial of Its Long-Acting Human Growth Hormone in the U.S. 8Advanced Life Sciences Sees Funding Opportunity for Restanza in New HHS Medical Countermeasure Report 2Advanced Life Sciences Sees Funding Opportunity for Restanza in New HHS Medical Countermeasure Report 3Advanced Life Sciences Sees Funding Opportunity for Restanza in New HHS Medical Countermeasure Report 4Advanced Life Sciences Sees Funding Opportunity for Restanza in New HHS Medical Countermeasure Report 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: